Özge Baykan Çopuroğlu
doi.org/10.36647/JPRI/05.02.A004
Abstract :
Polycystic ovary syndrome (PCOS) is a common endocrine disorder affecting reproductive-aged women, characterized by metabolic
dysfunction, hyperandrogenism, and ovulatory disturbances. Exercise has emerged as a key non-pharmacological strategy to manage both
metabolic and reproductive complications of the syndrome. This review aims to synthesize evidence from the past decade (2014–2024) on the
effects of structured exercise interventions, including aerobic, resistance, and high-intensity interval training (HIIT) on metabolic and
reproductive health outcomes in women with PCOS. A narrative review was conducted following PRISMA guidelines. Electronic databases
(PubMed, Scopus, and Web of Science) were systematically searched for studies published between January 2014 and December 2024.
Eligible studies included randomized controlled trials, cohort studies, and systematic reviews examining the independent effects of exercise
on insulin sensitivity, body composition, ovulation, menstrual function, and hormonal profiles in women diagnosed with PCOS. Evidence
indicates that structured exercise significantly improves insulin resistance, fasting glucose, lipid profiles, and body composition in women
with PCOS. Reproductive benefits include increased menstrual regularity, improved ovulation, and reductions in serum testosterone levels.
These effects are observed across different exercise modalities and often occur independently of weight loss. Combined training (aerobic +
resistance) appears to provide the most comprehensive benefits. Exercise is a clinically effective and low-risk intervention that should be
integrated as a central component of PCOS management, regardless of BMI or phenotype. Personalized exercise prescriptions and
long-term adherence strategies are essential to maximize therapeutic outcomes. Future research should focus on standardized protocols and
long-term reproductive and metabolic follow-up
Keyword :Exercise Intervention, Insulin Resistance, Metabolic Health, Polycystic Ovary Syndrome, Reproductive Function.